Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092933090> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2092933090 endingPage "500" @default.
- W2092933090 startingPage "493" @default.
- W2092933090 abstract "SUMMARY Two hundred and seventy‐seven patients with epilepsy treated with diamox alone or in combination with other drugs have been described. All patients had been followed for at least three years. The treatment benefited some patients subject to myoclonic and akinetic seizures. It seemed of little benefit in the group of psychomotor or focal seizures. On a short‐term basis diamox proved to be at least as effective as the other recognized drugs in controlling petit mal or petit mal and grand mal seizures. However, under prolonged treatment diamox lost much of its effectiveness. A similar decline in the percentage of effective control was observed when tridione was used in the same group of patients. The need for longitudinal studies to give an adequate picture of the usefulness of anti‐epileptic drugs is further emphasized. RÉSUMÉ Description de 277 malades épileptiques traités par le diamox seul ou en combinaison avec d'autres médicaments. Tous ces malades ont été suivis pendant trois ans au moins. Le traitement a été favorable à quelques malades sujets à des crises myocloniques et akinétiques. Il semble qu'il y ait eu peu d'amélioration dans le groupe de crises psychomotrices ou focales. Sur la base d'une courte période, le diamox s'est révélé au moins aussi efficace que les autres médicaments reconnus dans le traitement des crises de petit mal et de grand mal du type centrencéphalique. Toutefois le diamox perd une grande partie de son efficacité lors d'un traitement prolongé. Un abaissement de même genre du pourcentage des traitements efficaces a été observé lors de l'administration de tridione au même groupe de malades. Les auteurs insistent ensuite sur la nécessité de poursuivre les études envisageant l'obtention d'une image adéquate de l'utilité des médicaments anti‐épileptiques." @default.
- W2092933090 created "2016-06-24" @default.
- W2092933090 creator A5018313417 @default.
- W2092933090 creator A5033300783 @default.
- W2092933090 date "1959-01-01" @default.
- W2092933090 modified "2023-10-17" @default.
- W2092933090 title "A Long‐term Follow‐up of Acetazolamide (Diamox) in the Treatment of Epilepsy" @default.
- W2092933090 cites W1519146088 @default.
- W2092933090 cites W1926277669 @default.
- W2092933090 cites W1984413155 @default.
- W2092933090 cites W1992958582 @default.
- W2092933090 cites W2016755072 @default.
- W2092933090 cites W2029544451 @default.
- W2092933090 cites W2066219746 @default.
- W2092933090 cites W2086778263 @default.
- W2092933090 cites W2087001686 @default.
- W2092933090 cites W2093845902 @default.
- W2092933090 cites W2154070187 @default.
- W2092933090 doi "https://doi.org/10.1111/j.1528-1157.1959.tb04283.x" @default.
- W2092933090 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14418080" @default.
- W2092933090 hasPublicationYear "1959" @default.
- W2092933090 type Work @default.
- W2092933090 sameAs 2092933090 @default.
- W2092933090 citedByCount "49" @default.
- W2092933090 countsByYear W20929330902012 @default.
- W2092933090 countsByYear W20929330902013 @default.
- W2092933090 countsByYear W20929330902015 @default.
- W2092933090 countsByYear W20929330902016 @default.
- W2092933090 countsByYear W20929330902020 @default.
- W2092933090 countsByYear W20929330902021 @default.
- W2092933090 countsByYear W20929330902022 @default.
- W2092933090 crossrefType "journal-article" @default.
- W2092933090 hasAuthorship W2092933090A5018313417 @default.
- W2092933090 hasAuthorship W2092933090A5033300783 @default.
- W2092933090 hasConcept C118552586 @default.
- W2092933090 hasConcept C187212893 @default.
- W2092933090 hasConcept C2777405951 @default.
- W2092933090 hasConcept C2778186239 @default.
- W2092933090 hasConcept C29456083 @default.
- W2092933090 hasConcept C3017755710 @default.
- W2092933090 hasConcept C3019728164 @default.
- W2092933090 hasConcept C42219234 @default.
- W2092933090 hasConcept C71924100 @default.
- W2092933090 hasConceptScore W2092933090C118552586 @default.
- W2092933090 hasConceptScore W2092933090C187212893 @default.
- W2092933090 hasConceptScore W2092933090C2777405951 @default.
- W2092933090 hasConceptScore W2092933090C2778186239 @default.
- W2092933090 hasConceptScore W2092933090C29456083 @default.
- W2092933090 hasConceptScore W2092933090C3017755710 @default.
- W2092933090 hasConceptScore W2092933090C3019728164 @default.
- W2092933090 hasConceptScore W2092933090C42219234 @default.
- W2092933090 hasConceptScore W2092933090C71924100 @default.
- W2092933090 hasIssue "1-5" @default.
- W2092933090 hasLocation W20929330901 @default.
- W2092933090 hasLocation W20929330902 @default.
- W2092933090 hasOpenAccess W2092933090 @default.
- W2092933090 hasPrimaryLocation W20929330901 @default.
- W2092933090 hasRelatedWork W1974427186 @default.
- W2092933090 hasRelatedWork W1984451203 @default.
- W2092933090 hasRelatedWork W2027611973 @default.
- W2092933090 hasRelatedWork W2067813594 @default.
- W2092933090 hasRelatedWork W2086190002 @default.
- W2092933090 hasRelatedWork W2116164633 @default.
- W2092933090 hasRelatedWork W2397720922 @default.
- W2092933090 hasRelatedWork W2410858661 @default.
- W2092933090 hasRelatedWork W2411892141 @default.
- W2092933090 hasRelatedWork W2413928128 @default.
- W2092933090 hasVolume "1" @default.
- W2092933090 isParatext "false" @default.
- W2092933090 isRetracted "false" @default.
- W2092933090 magId "2092933090" @default.
- W2092933090 workType "article" @default.